Vulvovaginitis in healthy women
Tóm tắt
Từ khóa
Tài liệu tham khảo
Berg AO, Heidrich RD, Fihn SD, et al. Establishing the cause of symptoms in women in a family practice.JAMA. 1984;251:620–625.
Geiger AM, Foxman B, Gillespie BW. Epidemiology of vulvovaginal candidiasis among university student.Am J Pub Health. 1995;85:1146–1148.
Geiger AM, Foxman B. Risk factors in vulvovaginal candidiasis: a case-control study among college students.Epidemiology. 1996;182–187.
Odds FC. Candidiasis of the genitalia. In: Odd RC, ed. Candidaand Candidosis: A Review and Bibliography. 2nd ed. London: Balliere Tindal, 1988;124–135.
Horowitz BJ, Giaquinta D, Ito S. Evolving pathogens in vulvovaginal candidiasis: implications for patient care.J Clin Pharmacol. 1992;32:248–255.
Ferris DG, Dekle C, Litaker MS. Women’s use of over-the-counter antifungal pharmaceutical products for gynecologic symptoms.J Fam Pract. 1996;42:595–600.
Reef S, Levine WC, McNeil MM, et al. Treatment options for vulvovaginal candidiasis. Background paper for development of 1993 STD treatment recommendations.Clin Infect Dis. 1995;20(Suppl):580–590.
Sobel JD, Brooker D, Stein GE, et al. Single oral dose fluconazole compared with conventional topical therapy ofCandida vaginitis.Am J Obstet Gynecol. 1995;172:1263–1268.
Houang ET, Chappatte, Byrne D, Macrae PV, Thoiper JE. Fluconazole levels in plasma and vaginal secretions of patients with the 150 mg single dose and rate of eradication of infections in vaginal candidiasis.Antimicrob Ag Chem. 1990;34:909–913.
Sobel JD, Chaim W. Treatment ofCandida glabrata vaginitis: a retrospective review of boric acid therapy.Clin Infect Dis. 1997;24:649–652.
Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal canidiasis.Am J Obstet Gynecol. 1985;152:924–934.
Vazquez JA, Sobel JD, Demitriou R, Vaishampayan J, Lynch M, Zervos MJ. Karyotyping ofC. albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis.J Infect Dis. 1994;170:1566–1569.
Spinillo A, Carrata L, Pizzoli G. Recurrent vulvovaginal candidiasis: Results of a cohort study of sexual transmission and intestinal reservoir.J Reproduct Med. 1992;37:343–347.
Fidel PJ Jr, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis.Clin Micro Rev. 1996;9:335–348.
Chaim W, Foxman B, Sobel JD. Association of recurrent vaginal candidiasis and secretory ABO + Lewis phenotype.J Infect Dis. 1997;176:828–830.
Sobel JD, Chaim W. Vaginal microbiology of women with recurrent vulvovaginal candidiasis.J Clin Micro. 1996;34:2497–2502.
Sobel JD, Vazquez JA. Symptomatic vulvovaginitis due to resistantCandida albicans in a female who was not infected with human immunodeficiency virus.Clin Infect Dis. 1996;22:726–727.
Lossick JC. Epidemiology of urogenital trichomoniasis. In Honigberg BM, ed.Trichomonads Parasitic in Humans. New York: Springer-Verlag; 1990;311–323.
Luga M, Manoka AT, Kivuvu AT, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: result from cohort study.AIDS. 1993;7:95–102.
Wolner-Hanssen P, Krieger JN, Stevens CD et al. Clinical manifestations of vaginal trichomoniasis.JAMA. 1989;261:571–576.
Soper DE, Bump RC, Hurt WR. Bacterial vaginosis and trichomoniasis are risk factors for cuff cellulitis after abdominal hysterectomy.Am J Obstet Gynecol. 1990;163:1016–1021.
Krieger JN, Tam MR, Stevens CE, et al. Diagnosis of trichomoniasis: comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens.JAMA. 1988;259:1223–1227.
DeMeo LR, Draper DL, McGregor JA, et al. Evaluation of a deoxyribonucleic acid probe for the detection ofTrichomonas vaginalis in vaginal secretions.Am J Obstet Gynecol. 1996;174:1339–1342.
Nyirjesy P, Weitz MV, Gelone SP, Fekete T. Paramomycin for nitroimidazole-resistant trichomoniasis.Lancet. 1995;346:1100.
Kurohara ML, Kwong FK, Lebherz TB, Klaustermeyer WB. Metronidazole hypersensitivity and oral desensitization.J Allerg Clin Immunol. 1991;88:279–280.
Hillier SL, Holmes KK. Bacterial Vaginosis In:Sexually Transmitted Diseases. Holmes KK, Mardh PA, Sparling PF, et al, eds. New York: McGraw-Hill; 1990;547–560.
Eschenbach DA, Davick PR, Williams BL. Prevalence of hydrogen peroxide-producingLactobacillus species in normal women and women with bacterial vaginosis.J Clin Microbiol. 1989;27:251–256.
Gardner H, Dukes CD.Hemophilus vaginalis vaginitis: a newly defined specific infection previously classified “non-specific” vaginitis.Am J Obstet Gynecol. 1955;69:962–976.
Amsel R, Totten PA, Speigel CA, Chen KS, Eschenbach DA, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations.Am J Med. 1983;74:14–22.
Eschenbach DA, Hillier SL, Critchlow C, Stevens C, DeRauen T, Holmes KK. Diagnosis and clinical manifestations of bacterial vaginosis.Am J Obstet Gynecol. 1988;158:819–828.
Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation.J Clin Microbiol. 1991;29:297–301.
Sheiness D, Dix K, Watanabe S, Hillier SL. High levels ofGardnerella vaginalis detected with an oligonucleotide probe combined with elevated pH as a diagnostic indicator of bacterial vaginosis.J Clin Micro. 1992;30:642–645.
Oleen-Burkey MA, Hillier SL. Pregnancy complications associated with bacterial vaginosis and their estimated costs.Infect Dis Obstet Gynecol. 1995;3:149–157.
Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity.N Engl J Med. 1988;319:971–978.
Eschenbach DA. Bacterial vaginosis: emphasis on upper genital tract complications.Obstet Gynecol Clin North Am. 1989;16:593–610.
Kurk T, Sivonen A, Renkonen O, Savia F, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcomes.Obstet Gynecol. 1992;80:173–177.
Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonization of the genital tract and subsequent preterm delivery and late miscarriage.Br Med J. 1994;308:295–298.
McGregor JA, French JJ, Parker R, et al. Prevention of premature birth by screening and treatment of common genital tract infections: results of a propsective controlled evaluation.Am J Obstet Gynecol. 1995;173:157–167.
Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study.Am J Obstet Gynecol. 1994;71:345–349.
Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RD. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.N Engl J Med. 1995;333:1732–1736.
Korn AP, Bolan G, Padian N, et al. Plasma cell endometritis in women with symptomatic bacterial vaginosis.Obstet Gynecol. 1995;85:387–390.
Platz-Christensen JJ, Sundstrom E, Larsson PG. Bacterial vaginosis and cervical intraepithelial neoplasia.Acta Obstet Gynecol Scand. 1994;73:586–588.
Peters N, Van Leeuwen AM, Pieters WJLM, Holleman H, Quint WGV, Burger MPM. Bacterial vaginosis is not important in the etiology of cervical neoplasia: a survey of women with dyskariotic smears.Sex Trans Dis. 1995;22:296–302.
Joesoef MR, Schmid GP. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.Clin Infect Dis. 1995;20(Suppl 1):572–579.
Ferris DG, Litaker MS, Woodward L, Marhis D, Hendrich J. Treatment of bacterial vaginosis: a comparison of oral metronidazole: metronidazole vaginal gel and clindamycin vaginal cream.J Fam Pract. 1995;41:443–449.
Ahmed-Jushuf, IH Shahmanesh M, Arya OP. The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream: results of a multicenter, double blind, placebo controlled trial.Genitourin Med. 1995;71:254–256.
Sobel JD. Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy.Am J Obstet Gynecol. 1994;171:1215–1220.